Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Early Phase 1
2(50.0%)
4Total
N/A(2)
Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04096443Early Phase 1Active Not Recruiting

Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis

Role: collaborator

NCT05144750Not ApplicableCompleted

Fruit and Vegetable Prescription in the Community Health Center Setting

Role: collaborator

NCT05081271Early Phase 1Terminated

COVID-19 Booster Vaccination in Persons With Multiple Sclerosis

Role: collaborator

NCT03949296Not ApplicableCompleted

Mindfulness Meditation in Treating Insomnia in Multiple Sclerosis

Role: collaborator

All 4 trials loaded